Help | RSS Feed



AxoGen, Inc. (NASD:AXGN) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Axogen, Inc. (NASD:AXGN) seasonal charts above shows that a Buy Date of December 10 and a Sell Date of March 1 has resulted in a geometric average return of 16.33% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 9.15% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Axogen Inc is a medical technology company. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. The firm’s product portfolio includes Avance nerve graft, Axoguard nerve connector and nerve protector, Avive soft tissue membrane, Axotouch two-point membrane and Acroval Neurosensory and motor testing system. Its products are available in the United States, Canada, the United Kingdom and other European and International countries. The company generates the majority of its sales in the United States.

To download AXGN seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore